Triglav Skladi’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.8M Hold
3,450
– – 0.09% 117
2026
Q2
$1.71M Hold
3,450
– – 0.09% 113
2026
Q1
$1.54M Hold
3,450
– – 0.11% 102
2025
Q4
$1.56M Hold
3,450
– – 0.1% 103
2025
Q3
$1.35M Hold
3,450
– – 0.09% 97
2025
Q2
$1.54M Hold
3,450
– – 0.11% 92
2025
Q1
$1.67M Hold
3,450
– – 0.14% 79
2024
Q4
$1.39M Buy
+3,450
New +$1.6M 0.11% 94

Other funds holding VRTX

Triglav Skladi's VRTX Position: Q3 2026 in Review

Triglav Skladi held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2026 at 3,450 shares worth $1.8M. The position accounts for 0.09% of the portfolio, ranked #117.

Triglav Skladi first reported a position in VRTX in Q4 2024 and has held it in 8 quarters since. 1,797 funds tracked by Wall St. Rank hold VRTX as of Q3 2026.

  • Triglav Skladi held 3,450 shares of Vertex Pharmaceuticals worth $1.8M as of Q3 2026.
  • Triglav Skladi left its Vertex Pharmaceuticals share count unchanged in Q3 2026.
  • Vertex Pharmaceuticals made up 0.09% of Triglav Skladi's portfolio in Q3 2026, its #117 holding.
  • Triglav Skladi first reported a position in Vertex Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
  • 1,797 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2026.

Based on Triglav Skladi's 13F filing for Q3 2026, filed 6 Nov 2026.